Ameliorating effect of luteolin on memory impairment in an Alzheimer's disease model
- PMID: 27035793
- PMCID: PMC4838167
- DOI: 10.3892/mmr.2016.5052
Ameliorating effect of luteolin on memory impairment in an Alzheimer's disease model
Abstract
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative disorder. It is characterized by the formation of amyloid plaques and neurofibrillary tangles in the brain, the degeneration of cholinergic neurons and neuronal cell death. The present study aimed to investigate the effect of luteolin, a flavonoid compound, on memory impairment in a streptozotocin (STZ)‑induced Alzheimer's rat model. Morris water maze and probe tests were performed to examine the effect of luteolin treatment on cognition and memory. The effect of luteolin on CA1 pyramidal layer thickness was also examined. The results demonstrated that luteolin significantly ameliorated the spatial learning and memory impairment induced by STZ treatment. STZ significantly reduced the thickness of CA1 pyramidal layer and treatment of luteolin completely abolished the inhibitory effect of STZ. Our results suggest that luteolin has a potentially protective effect on learning defects and hippocampal structures in AD.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4838167/bin/MMR-13-05-4215-g00.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4838167/bin/MMR-13-05-4215-g01.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4838167/bin/MMR-13-05-4215-g02.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4838167/bin/MMR-13-05-4215-g03.gif)
Similar articles
-
The neuroprotective effect of a triazine derivative in an Alzheimer's rat model.Acta Med Iran. 2015;53(1):8-16. Acta Med Iran. 2015. PMID: 25597599
-
Protective effects of 5-HT1A receptor antagonist and 5-HT2A receptor agonist on the biochemical and histological features in a rat model of Alzheimer's disease.J Chem Neuroanat. 2019 Mar;96:140-147. doi: 10.1016/j.jchemneu.2019.01.008. Epub 2019 Jan 23. J Chem Neuroanat. 2019. PMID: 30684605
-
Streptozotocin Induces Mild Cognitive Impairment at Appropriate Doses in Mice as Determined by Long-Term Potentiation and the Morris Water Maze.J Alzheimers Dis. 2016 Jul 27;54(1):89-98. doi: 10.3233/JAD-150979. J Alzheimers Dis. 2016. PMID: 27472873
-
Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease.Exp Gerontol. 2017 Sep;95:39-43. doi: 10.1016/j.exger.2017.05.014. Epub 2017 May 17. Exp Gerontol. 2017. PMID: 28528007 Review.
-
Bioavailability and Pharmaco-therapeutic Potential of Luteolin in Overcoming Alzheimer's Disease.CNS Neurol Disord Drug Targets. 2019;18(5):352-365. doi: 10.2174/1871527318666190319141835. CNS Neurol Disord Drug Targets. 2019. PMID: 30892166 Review.
Cited by
-
Luteolin for neurodegenerative diseases: a review.Pharmacol Rep. 2024 Aug;76(4):644-664. doi: 10.1007/s43440-024-00610-8. Epub 2024 Jun 21. Pharmacol Rep. 2024. PMID: 38904713 Review.
-
Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects.Neurochem Res. 2024 Aug;49(8):1926-1944. doi: 10.1007/s11064-024-04177-x. Epub 2024 Jun 1. Neurochem Res. 2024. PMID: 38822985 Review.
-
Review on anti-alzheimer drug development: approaches, challenges and perspectives.RSC Adv. 2024 Apr 5;14(16):11057-11088. doi: 10.1039/d3ra08333k. eCollection 2024 Apr 3. RSC Adv. 2024. PMID: 38586442 Free PMC article. Review.
-
Flavonoids and Alzheimer's disease: reviewing the evidence for neuroprotective potential.Mol Cell Biochem. 2024 Apr 3. doi: 10.1007/s11010-023-04922-w. Online ahead of print. Mol Cell Biochem. 2024. PMID: 38568359 Review.
-
A prospective review of the health-promoting potential of Jing Si Herbal Tea.Tzu Chi Med J. 2024 Jan 12;36(1):1-22. doi: 10.4103/tcmj.tcmj_194_23. eCollection 2024 Jan-Mar. Tzu Chi Med J. 2024. PMID: 38406577 Free PMC article. Review.
References
-
- Zhu Z, Yan J, Jiang W, Yao XG, Chen J, Chen L, Li C, Hu L, Jiang H, Shen X. Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both β-amyloid production and clearance. J Neurosci. 2013;33:13138–13149. doi: 10.1523/JNEUROSCI.4790-12.2013. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous